Future Financial Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Future Financial Wealth Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,500	Closed	-$712	–	126
2022 Q4	$712	Hold	13,500	–	–	﹤0.01%	117
2022 Q3	$24K	Buy	+13,500	New	+$21K	0.03%	121
2022 Q2	–	Sell	-7,000	Closed	-$14K	–	530
2022 Q1	$14K	Buy	+7,000	New	+$13.8K	0.01%	401

Other funds holding CLVS

RMC

Resources Management Corp West Hartford, Connecticut $794M AUM 25.46% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Future Financial Wealth Management's CLVS Position: Q1 2023 in Review

Future Financial Wealth Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2023, closing a stake of 13,500 shares — an estimated $712 sold.

Future Financial Wealth Management first reported a position in CLVS in Q1 2022 and held it in 3 quarters. The position peaked at $24K in Q3 2022. 2 funds tracked by Wall St. Rank hold CLVS as of Q1 2023.

Future Financial Wealth Management reported no remaining Clovis Oncology, Inc. position as of Q1 2023 after selling out during the quarter.
Future Financial Wealth Management sold 13,500 Clovis Oncology, Inc. shares in Q1 2023, an estimated $712.
Future Financial Wealth Management first reported a position in Clovis Oncology, Inc. in Q1 2022 and held it in 3 quarters.
Future Financial Wealth Management's Clovis Oncology, Inc. position peaked at $24K in Q3 2022.
2 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2023.

Based on Future Financial Wealth Management's 13F filing for Q1 2023, filed 4 Apr 2023.